« Back
Home /
Motesanib

Motesanib

Manufacturer	TargetMol
Category	Oncology Reagents & Chemicals Molecules By Organ Colorectal Cancer
Type	Molecules
Specific against	other
Amount	1mg
Item no.	TMO-T2288-1mg
Targets	RET, KIT
CASRN	453562-69-1
eClass 6.1	32169090
eClass 9.0	32169090
Available
Description	Motesanib is an orally bioavailable receptor tyrosine kinase inhibitor with potential antineoplastic activity. AMG 706 selectively targets and inhibits vascular endothelial growth factor (VEGFR), platelet-derived growth factor (PDGFR), Kit, and Ret receptors, thereby inhibiting angiogenesis and cellular proliferation.
Formulate	C22H23N5O
Shipping temperature	Cool Pack
Smeles	CC1(C)CNC2=C1C=CC(NC(=O)C1=C(NCC3=C C=NC=C3)N=CC=C1)=C2
Storage Temperature	-20° C

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1mg

available

Delivery expected until 5/23/2024